Australian Orphan Fee Waivers To Expire As Transition Period Ends
Executive Summary
The transition period for Australia’s new orphan drug program is coming to an end, and sponsors may need to take action if they want to keep their orphan status - and fee waivers - beyond the end of June.
You may also be interested in...
Australia Announces A “Fairer” Orphan Drugs Program, With New Eligibility And Validity Criteria
New orphan drug designations under Australia’s reformed program will lapse after six months, although there is a 12-month transitional period for existing designations.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.